These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24461268)

  • 1. The merits of cell salvage in arthroplasty surgery: an overview.
    Dusik CJ; Hutchison C; Langelier D
    Can J Surg; 2014 Feb; 57(1):61-6. PubMed ID: 24461268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial.
    Voorn VMA; Marang-van de Mheen PJ; van der Hout A; Hofstede SN; So-Osman C; van den Akker-van Marle ME; Kaptein AA; Stijnen T; Koopman-van Gemert AWMM; Dahan A; Vliet Vlieland TPMM; Nelissen RGHH; van Bodegom-Vos L
    Implement Sci; 2017 May; 12(1):72. PubMed ID: 28558843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative autologous blood salvage drains--are they useful in primary uncemented hip and knee arthroplasty? A prospective study of 186 cases.
    Jones HW; Savage L; White C; Goddard R; Lumley H; Kashif F; Gurusany K
    Acta Orthop Belg; 2004 Oct; 70(5):466-73. PubMed ID: 15587036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusions increase complications and infections after hip and knee arthroplasty: An analysis of 2760 cases.
    Klasan A; Dworschak P; Heyse TJ; Malcherczyk D; Peterlein CD; Schüttler KF; Lahner M; El-Zayat BF
    Technol Health Care; 2018; 26(5):825-832. PubMed ID: 29914043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
    So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
    Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of blood management in patients having a total hip or knee arthroplasty.
    Bierbaum BE; Callaghan JJ; Galante JO; Rubash HE; Tooms RE; Welch RB
    J Bone Joint Surg Am; 1999 Jan; 81(1):2-10. PubMed ID: 9973048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.
    Sun Q; Li J; Chen J; Zheng C; Liu C; Jia Y
    BMJ Open; 2019 Jan; 9(1):e024350. PubMed ID: 30696680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for infection, revision, death, blood transfusion and longer hospital stay 3 months and 1 year after primary total hip or knee arthroplasty.
    Rhee C; Lethbridge L; Richardson G; Dunbar M
    Can J Surg; 2018 Jun; 61(3):165-176. PubMed ID: 29806814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009.
    Saleh A; Small T; Chandran Pillai AL; Schiltz NK; Klika AK; Barsoum WK
    J Bone Joint Surg Am; 2014 Sep; 96(18):e155. PubMed ID: 25232085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative blood salvage versus allogeneic blood transfusion in total knee and hip arthroplasty: a literature review.
    Leigheb M; Pogliacomi F; Bosetti M; Boccafoschi F; Sabbatini M; Cannas M; Grassi F
    Acta Biomed; 2016 Apr; 87 Suppl 1():6-14. PubMed ID: 27104315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients.
    So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
    Anesthesiology; 2014 Apr; 120(4):839-51. PubMed ID: 24424070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective Cohort Study Comparing Complications, Readmission, Transfusion, and Length of Stay of Patients Undergoing Simultaneous and Staged Bilateral Total Hip Arthroplasty.
    Guo SJ; Shao HY; Huang Y; Yang DJ; Zheng HL; Zhou YX
    Orthop Surg; 2020 Feb; 12(1):233-240. PubMed ID: 31958880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-stage versus 2-stage bilateral total joint arthroplasty: a matched cohort study.
    Saini R; Powell J; Sharma R; Puloski S; Mahdavi S; Smith C; Johnston K
    Can J Surg; 2020 Apr; 63(2):E167-E173. PubMed ID: 32302083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-operative blood salvage in total hip and knee arthroplasty.
    Dan M; Liu D; Martos SM; Beller E
    J Orthop Surg (Hong Kong); 2016 Aug; 24(2):204-8. PubMed ID: 27574264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is postoperative cell salvage necessary in total hip or knee replacement? A meta-analysis of randomized controlled trials.
    Xie J; Feng X; Ma J; Kang P; Shen B; Yang J; Zhou Z; Pei F
    Int J Surg; 2015 Sep; 21():135-44. PubMed ID: 26253852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a blood management protocol on transfusion rates and outcomes following total hip and knee arthroplasty.
    Frew N; Alexander D; Hood J; Acornley A
    Ann R Coll Surg Engl; 2016 Jul; 98(6):380-6. PubMed ID: 27055406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
    Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
    Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia.
    Borghi B; Casati A
    Eur J Anaesthesiol; 2000 Jul; 17(7):411-7. PubMed ID: 10964142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative allogenic blood transfusion increases the incidence of postoperative deep vein thrombosis in total knee and hip arthroplasty.
    Jiang T; Song K; Yao Y; Pan P; Jiang Q
    J Orthop Surg Res; 2019 Jul; 14(1):235. PubMed ID: 31337430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty.
    George DA; Sarraf KM; Nwaboku H
    Eur J Orthop Surg Traumatol; 2015 Jan; 25(1):129-33. PubMed ID: 24756178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.